Luteal Support in Frozen-Thawed Embryo Transfer Cycles
Status:
Not yet recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This study evaluates the clinical efficacy of 3 different luteal phase support in patients
undergoing frozen-thawed embryo transfer cycles. Endometrium preparation will be hormone
replacement in all cycles. Starting from day 11, group 1 will receive 100 mg micronized
progesterone parenteral daily injections, group 2 will receive 90 mg bioadhesive gel vaginal
twice daily and group 3 will receive 40 mg oral dydrogesterone daily tablets.